Omnia SanaPlant Comparison
Eyebright vs Licorice root
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Eyebright and Licorice root: they share 7 indicated uses (arthritis / joint pain, cough, infection (general), …); 1 pharmacological action in common.
Evidence face-off — shared uses
| Condition | Eyebright | Licorice root | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 1/10 | Comparable evidence |
| Cough | 1/10 | 1/10 | Comparable evidence |
| Infection (general) | 2/10 | 1/10 | Comparable evidence |
| Inflammation (general) | 2/10 | 1/10 | Comparable evidence |
| Respiratory support | 1/10 | 1/10 | Comparable evidence |
| Skin irritation | 1/10 | 1/10 | Comparable evidence |
| Wounds | 1/10 | 1/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Give the plant its anti-inflammatory action on irritated tissue.
The principal sweet-tasting compound, about 50 times sweeter than sucrose; responsible for the anti-inflammatory, antiviral and gastroprotective activity and also for the pseudoaldosteronism risk on prolonged high-dose use.
Antioxidant and antimicrobial polyphenols, including the skin-lightening compound glabridin.
Minor supporting constituents of the root.
Pharmacological Actions
Astringent and anti-inflammatory for eye irritation, redness and conjunctivitis (traditional, as an eye compress or bath) - an open prospective cohort of Euphrasia single-dose eye drops reported recovery or clear improvement in most patients with conjunctivitis
Traditional & Indicated Uses
Eases eye strain and watery, itchy eyes from allergy (hay fever / allergic conjunctivitis)
inferred from anti-inflammatory action
inferred from anticancer action
Soothes upper-respiratory catarrh and mild infection (traditional)
Astringent and anti-inflammatory for eye irritation, redness and conjunctivitis (traditional, as an eye compress or bath) - an open prospective cohort of Euphrasia single-dose eye drops reported recovery or clear improvement in most patients with conjunctivitis; Eases eye strain and watery, itchy eyes from allergy (hay fever / allergic conjunctivitis)
Eases eye strain and watery, itchy eyes from allergy (hay fever / allergic conjunctivitis)
Soothes upper-respiratory catarrh and mild infection (traditional)
inferred from anti-inflammatory action
Soothes upper-respiratory catarrh and mild infection (traditional)
inferred from anti-inflammatory action
inferred from gastroprotective action
inferred from anti-inflammatory action
inferred from expectorant action
inferred from gastroprotective action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from antispasmodic action
inferred from antispasmodic action
inferred from expectorant action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
CRITICAL: do not put non-sterile, homemade eyebright preparations directly into the eye - this risks serious eye infection. Use only commercially prepared sterile products in the eye, or apply a strained, cooled infusion as a compress over closed eyelids.
Traditional use only; persistent eye symptoms, pain, discharge or vision change need assessment by an eye-care professional. Safety in pregnancy and breastfeeding is not established.
Avoid prolonged use of whole licorice root in large doses. May cause pseudoaldosteronism (hypertension, oedema, hypokalaemia). Contraindicated in hypertension, renal failure, liver disease, hypokalaemia, and pregnancy. DGL form is safer for prolonged gastric use. Interactions with antihypertensives, diuretics, and corticosteroids.
Duke (2002) rates licorice as ++ and documents extensive activities. Glycyrrhizin (the key compound) has anti-inflammatory, antiulcer, antiviral, and adrenal-stimulant properties. Duke highlights an important safety concern: chronic use of licorice can cause pseudoaldosteronism — sodium retention, potassium loss, edema, and hypertension — due to glycyrrhizin's inhibition of cortisol metabolism. This effect is typically seen with >50 g licorice/day for more than 6 weeks. Deglycyrrhizinated licorice (DGL) avoids this side effect. Dose: 5–15 g dried root daily. Contraindicated in hypertension, kidney disease, low potassium, liver cirrhosis, and in combination with diuretics or corticosteroids (Duke, 2002).
External Ids
Botanical Description
Small, semi-parasitic annual herb (drawing some nutrients from the roots of neighbouring grasses) with tiny, opposite, toothed leaves and delicate, two-lipped white to pale lilac flowers marked with purple veins and a yellow throat spot, giving a bright, eye-like appearance that inspired both its common and Latin names.[11]
Herbaceous perennial legume with pinnately compound leaves of small, oval, slightly sticky leaflets. Pale blue-violet to lilac pea-like flowers are borne in loose spikes, followed by small, flattened, oblong pods. The sweet-tasting rhizome and root system, brownish-grey outside and bright yellow inside, is the medicinal part, spreading extensively underground via stolons.[1]
Habitat
Grows in short, unimproved grassland, pastures, meadows and dunes on well-drained soils, always in association with grasses on which it partially parasitises; native to Europe.[11]
Grows in dry, sunny, deep-soiled sites, riverbanks and open scrub; native to the Mediterranean region and Western to Central Asia, and cultivated widely for its root.[1]
Harvesting
The flowering aerial parts are cut in summer while in flower and dried in a warm, shaded, airy place.[11]
The root and rhizome are dug in autumn from plants at least three to four years old, when glycyrrhizin content is highest, then cleaned and dried; sold whole, cut, or as processed extract.[1]
Traditional Uses
Licorice root is one of the oldest and most widely used herbs in the world, with a documented history across Chinese, Ayurvedic, Greek and European traditional medicine as a soothing demulcent and expectorant for coughs and sore throat, a gastroprotective remedy for stomach discomfort and ulcers, and a harmonising, sweetening addition to herbal formulas.[1]
Preparations
Strained, cooled infusion applied as a compress over closed eyelids, or used (only when sterile, commercially prepared) as an eyewash for irritated or red eyes.
Commercially prepared, sterile Euphrasia eye drops used for conjunctivitis; a prospective clinical cohort found improvement in most users.
Dosage
No dose is given here because no official posology exists. The HMPC assessed eyebright and DECLINED to establish a herbal monograph, concluding that the efficacy of the claimed uses is undocumented and that external eye application of ex tempore (home-prepared) preparations is 'not hygienic and not safe', so therapeutic use cannot be recommended. Traditional sources describe a strained, cooled infusion used as a compress, but that is precisely the practice the HMPC advised against; nothing home-prepared should be put in or on the eye. Educational reference only, not a prescription.
The EU herbal monograph gives, for adults and elderly, 1.5-2 g of the comminuted root in 150 mL of boiling water as an infusion or decoction 2 to 4 times daily, taken one cup after meals; a soft extract (DER 1:0.4-0.5) at 32 mg 2-3 times daily, not exceeding 160 mg daily, is also listed. The monograph directs that it is NOT to be used for more than 4 weeks, and is not recommended under 18 years - the duration limit matters because prolonged licorice use causes pseudoaldosteronism (sodium and water retention, potassium loss, raised blood pressure). Deglycyrrhizinated licorice (DGL) is preferred where prolonged use is intended. Educational reference only, not a prescription.
References
Lookalikes Review
Drug Class Interactions
Not documented
References & Sources
- Novy, P., Davidova, H., Serrano-Rojero, C.S., Rondevaldova, J. et al (2015) 'Composition and Antimicrobial Activity of Euphrasia rostkoviana Hayne Essential Oil', Evidence-Based Complementary and Alternative Medicine, 2015, pp. 734101. doi:10.1155/2015/734101 Preclinical
https://doi.org/10.1155/2015/734101 - D'Ambrosio, M., Ciocarlan, A. and Aricu, A (2020) 'Minor acetylated metabolites from Euphrasia rostkoviana', Natural Product Research, 34(2), pp. 290-295. doi:10.1080/14786419.2018.1530227 Preclinical
https://doi.org/10.1080/14786419.2018.1530227 - Ververis, A., Kyriakou, S., Paraskeva, H., Panayiotidis, M.I. et al (2024) 'Chemical Characterization and Assessment of the Neuroprotective Potential of Euphrasia officinalis', International Journal of Molecular Sciences, 25(23), pp. 12902. doi:10.3390/ijms252312902 Preclinical
https://doi.org/10.3390/ijms252312902 - Meier-Girard, D., Gerstenberg, G., Stoffel, L., Kohler, T., Klein, S.D., Eschenmoser, M., Mitter, V.R., Nelle, M. and Wolf, U (2020) 'Euphrasia eye drops in preterm neonates with ocular discharge: a randomized double-blind placebo-controlled trial', Frontiers in Pediatrics, 8, pp. 449. doi:10.3389/fped.2020.00449 Randomized trial
https://doi.org/10.3389/fped.2020.00449 - Liu, Y., Hwang, E., Ngo, H.T.T., Perumalsamy, H., Kim, Y.J., Li, L. and Yi, T.H (2018) 'Protective effects of Euphrasia officinalis extract against ultraviolet B-induced photoaging in normal human dermal fibroblasts', International Journal of Molecular Sciences, 19(11), pp. 3327. doi:10.3390/ijms19113327 Preclinical
https://doi.org/10.3390/ijms19113327 - Porchezhian, E., Ansari, S.H. and Shreedharan, N.K (2000) 'Antihyperglycemic activity of Euphrasia officinale leaves', Fitoterapia, 71(5), pp. 522-526. doi:10.1016/s0367-326x(00)00204-5 Preclinical
https://doi.org/10.1016/s0367-326x(00)00204-5 - Sticher, O. and Salama, O (1981) 'Iridoid glucosides from Euphrasia rostkoviana', Planta Medica, 42(6), pp. 122-123. doi:10.1055/s-2007-971584 Preclinical
https://doi.org/10.1055/s-2007-971584 - Lorenz, P., Knittel, D.N., Conrad, J., Lotter, E.M., Heilmann, J., Stintzing, F.C. and Kammerer, D.R (2016) '1-Acetyl-3-[(3R)-hydroxyfatty acyl]glycerols: lipid compounds from Euphrasia rostkoviana Hayne and E. tetraquetra (Breb.) Arrond', Chemistry & Biodiversity, 13(5), pp. 602-612. doi:10.1002/cbdv.201500233 Preclinical
https://doi.org/10.1002/cbdv.201500233 - Gawenda-Kempczynska, D., Olech, M., Balcerek, M., Nowak, R., Zaluski, T. and Zaluski, D (2022) 'Phenolic acids as chemotaxonomic markers able to differentiate the Euphrasia species', Phytochemistry, 203, pp. 113342. doi:10.1016/j.phytochem.2022.113342 Preclinical
https://doi.org/10.1016/j.phytochem.2022.113342 - Benedec, D., Oniga, I., Hanganu, D., Vlase, A.M., Ielciu, I., Crisan, G., Fit, N., Niculae, M., Bab, T., Pall, E. and Vlase, L (2024) 'Revealing the Phenolic Composition and the Antioxidant, Antimicrobial and Antiproliferative Activities of Two Euphrasia sp. Extracts', Plants, 13(13), pp. 1790. doi:10.3390/plants13131790 Preclinical
https://doi.org/10.3390/plants13131790 - Herbal Reality (n.d.) 'Eyebright (Euphrasia officinalis): Benefits, Uses, Safety'. Available at: https://www.herbalreality.com/herb/eyebright/ Traditional / reference
https://www.herbalreality.com/herb/eyebright/ - Paduch, R. and colleagues (2014) 'Assessment of Eyebright (Euphrasia officinalis L.) Extract Activity in Relation to Human Corneal Cells Using In Vitro Tests'. doi:10.5152/balkanmedj.2014.8377 Traditional / reference
https://doi.org/10.5152/balkanmedj.2014.8377 - Stoss, M., Michels, C., Peter, E., Beutke, R. and Gorter, R.W (2000) 'Prospective cohort trial of Euphrasia single-dose eye drops in conjunctivitis', Journal of Alternative and Complementary Medicine, 6(6), pp. 499--508. doi:10.1089/acm.2000.6.499 Clinical study
https://doi.org/10.1089/acm.2000.6.499 - European Medicines Agency (HMPC) (2010) 'Public statement on Euphrasia officinalis L. and Euphrasia rostkoviana Hayne, herba'. Available at: https://www.ema.europa.eu/en/documents/herbal-report/final-public-statement-euphrasia-officinalis-l-and-euphrasia-rostkoviana-hayne-herba_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-report/final-public-statement-euphrasia-officinalis-l-and-euphrasia-rostkoviana-hayne-herba_en.pdf
- Pastorino, G., Cornara, L., Soares, S., Rodrigues, F. and Oliveira, M.B.P.P (2018) 'Liquorice (Glycyrrhiza glabra): A phytochemical and pharmacological review', Phytotherapy Research, 32(12), pp. 2323-2339. doi:10.1002/ptr.6178 Traditional / reference
https://doi.org/10.1002/ptr.6178 - Nazari, S., Rameshrad, M. and Hosseinzadeh, H (2017) 'Toxicological Effects of Glycyrrhiza glabra (Licorice): A Review', Phytotherapy Research, 31(11), pp. 1635-1650. doi:10.1002/ptr.5893 Traditional / reference
https://doi.org/10.1002/ptr.5893 - El-Saber Batiha, G., Magdy Beshbishy, A., El-Mleeh, A., Abdel-Daim, M.M. and Prasad Devkota, H (2020) 'Traditional Uses, Bioactive Chemical Constituents, and Pharmacological and Toxicological Activities of Glycyrrhiza glabra L. (Fabaceae)', Biomolecules, 10(3), pp. 352. doi:10.3390/biom10030352 Traditional / reference
https://doi.org/10.3390/biom10030352 - Wahab, S., Annadurai, S., Abullais, S.S., Das, G., Ahmad, W., Ahmad, M.F., Kandasamy, G., Vasudevan, R., Ali, M.S. and Amir, M (2021) 'Glycyrrhiza glabra (licorice): a comprehensive review on its phytochemistry, biological activities, clinical evidence and toxicology', Plants, 10(12), pp. 2751. doi:10.3390/plants10122751 Meta-analysis / review
https://doi.org/10.3390/plants10122751 - Markina, Y.V., Kirichenko, T.V., Markin, A.M., Yudina, I.Y., Starodubova, A.V., Sobenin, I.A. and Orekhov, A.N (2022) 'Atheroprotective effects of Glycyrrhiza glabra L', Molecules, 27(15), pp. 4697. doi:10.3390/molecules27154697 Meta-analysis / review
https://doi.org/10.3390/molecules27154697 - Jafari, F., Jafari, M., Moghadam, A.T., Emami, S.A., Jamialahmadi, T., Mohammadpour, A.H. and Sahebkar, A (2021) 'A review of Glycyrrhiza glabra (licorice) effects on metabolic syndrome', Advances in Experimental Medicine and Biology, 1328, pp. 385-400. doi:10.1007/978-3-030-73234-9_25 Meta-analysis / review
https://doi.org/10.1007/978-3-030-73234-9_25 - Schmid, C., Dawid, C., Peters, V. and Hofmann, T (2018) 'Saponins from European licorice roots (Glycyrrhiza glabra)', Journal of Natural Products, 81(8), pp. 1734-1744. doi:10.1021/acs.jnatprod.8b00022 Preclinical
https://doi.org/10.1021/acs.jnatprod.8b00022 - Kalani, K., Chaturvedi, V., Alam, S., Khan, F. and Srivastava, S.K (2015) 'Anti-tubercular agents from Glycyrrhiza glabra', Current Topics in Medicinal Chemistry, 15(11), pp. 1043-1049. doi:10.2174/1568026615666150317223323 Preclinical
https://doi.org/10.2174/1568026615666150317223323 - Frattaruolo, L., Carullo, G., Brindisi, M., Mazzotta, S., Bellissimo, L., Rago, V., Curcio, R., Dolce, V., Aiello, F. and Cappello, A.R (2019) 'Antioxidant and anti-inflammatory activities of flavanones from Glycyrrhiza glabra L. (licorice) leaf phytocomplexes: identification of licoflavanone as a modulator of NF-kB/MAPK pathway', Antioxidants, 8(6), pp. 186. doi:10.3390/antiox8060186 Preclinical
https://doi.org/10.3390/antiox8060186 - Eltahir, A.O.E., Omoruyi, S.I., Augustine, T.N., Luckay, R.C. and Hussein, A.A (2024) 'Neuroprotective effects of Glycyrrhiza glabra total extract and isolated compounds', Pharmaceuticals, 17(7), pp. 852. doi:10.3390/ph17070852 Preclinical
https://doi.org/10.3390/ph17070852 - Dastagir, G. and Rizvi, M.A (2016) 'Review - Glycyrrhiza glabra L. (liquorice)', Pakistan Journal of Pharmaceutical Sciences, 29(5), pp. 1727-1733. Meta-analysis / review
https://scholar.google.com/scholar?q=Review%20-%20Glycyrrhiza%20glabra%20L.%20%28liquorice%29 - European Medicines Agency (HMPC) (2013) 'Community herbal monograph on Glycyrrhiza glabra L. and/or Glycyrrhiza inflata Bat. and/or Glycyrrhiza uralensis Fisch., radix'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-glycyrrhiza-glabra-l-andor-glycyrrhiza-inflata-bat-andor-glycyrrhiza-uralensis-fisch-radix-first-version_en.pdf - Asl, M.N. and Hosseinzadeh, H (2008) 'Review of pharmacological effects of Glycyrrhiza sp', 22(6), pp. 709--724. Traditional / reference
https://scholar.google.com/scholar?q=Review%20of%20pharmacological%20effects%20of%20Glycyrrhiza%20sp. - Fiore, C. et al (2008) 'A history of the therapeutic use of liquorice in Europe', 99(3), pp. 317--324. doi:10.1016/j.jep.2005.04.015 Traditional / reference
https://doi.org/10.1016/j.jep.2005.04.015 - WHO (1999) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Takahashi, K., Yoshino, T., Maki, Y., Ishiuchi, K., Namiki, T., Ogawa-Ochiai, K., Minamizawa, K., Makino, T., Nakamura, T., Mimura, M. and Watanabe, K (2019) 'Identification of glycyrrhizin metabolites in humans and of a potential biomarker of liquorice-induced pseudoaldosteronism', Archives of Toxicology, 93(11), pp. 3111-3119. doi:10.1007/s00204-019-02588-2 Clinical study
https://doi.org/10.1007/s00204-019-02588-2 - Penninkilampi, R., Eslick, E.M. and Eslick, G.D (2017) 'The association between consistent licorice ingestion, hypertension and hypokalaemia: a systematic review and meta-analysis', Journal of Human Hypertension, 31(11), pp. 699-707. doi:10.1038/jhh.2017.45 Meta-analysis / review
https://doi.org/10.1038/jhh.2017.45 - Wu, T., Yang, J., Xia, J. and Sun, G (2024) 'Effects of licorice functional components intakes on blood pressure: a systematic review with meta-analysis and network toxicology', Nutrients, 16(21), pp. 3768. doi:10.3390/nu16213768 Meta-analysis / review
https://doi.org/10.3390/nu16213768 - af Geijerstam, P., Joelsson, A., Radholm, K. and Nystrom, F.H (2024) 'A low dose of daily licorice intake affects renin, aldosterone, and home blood pressure in a randomized crossover trial', The American Journal of Clinical Nutrition, 119(3), pp. 682-691. doi:10.1016/j.ajcnut.2024.01.011 Randomized trial
https://doi.org/10.1016/j.ajcnut.2024.01.011
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.